Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

TOLTERODINE Tartrate Tablets (GREENSTONE LLC)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our medical information is accurate, up to date, and scientifically balanced.

TOLTERODINE Tartrate Tablets (GREENSTONE LLC) Quick Finder

INDICATIONS AND USAGE

Tolterodine tartrate tablets are indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.

Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

The initial recommended dose of tolterodine tartrate tablets is 2 mg twice daily. The dose may be lowered to 1 mg twice daily based on individual response and tolerability. For patients with...

Did you find an answer to your question? Yes No

CONTRAINDICATIONS

Tolterodine tartrate tablets are contraindicated in patients with urinary retention, gastric retention, or uncontrolled narrow-angle glaucoma. Tolterodine tartrate is also contraindicated in patients who...

Did you find an answer to your question? Yes No

WARNINGS

Anaphylaxis and angioedema requiring hospitalization and emergency medical treatment have occurred with the first or subsequent doses of tolterodine tartrate. In the event of difficulty in breathing, upper airway...

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

The Phase 2 and 3 clinical trial program for tolterodine tartrate tablets included 3071 patients who were treated with tolterodine tartrate (N=2133) or placebo (N=938). The patients were treated with 1, 2...

Did you find an answer to your question? Yes No

OVERDOSAGE

A 27-month-old child who ingested 5 to 7 tolterodine tartrate tablets 2 mg was treated with a suspension of activated charcoal and was hospitalized overnight with symptoms of dry mouth. The child fully recovered....

Did you find an answer to your question? Yes No

DESCRIPTION

Tolterodine tartrate tablets contain tolterodine tartrate. The active moiety, tolterodine, is a muscarinic receptor antagonist. The chemical name of tolterodine tartrate is (R)-2-[3-[bis(1-methylethyl)-amino]1-...

Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

Tolterodine is a competitive muscarinic receptor antagonist. Both urinary bladder contraction and salivation are mediated via cholinergic muscarinic receptors.

After oral administration,...

Did you find an answer to your question? Yes No

CLINICAL STUDIES

Tolterodine tartrate tablets were evaluated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency in four randomized, double-blind, placebo-controlled, 12-...

Did you find an answer to your question? Yes No

HOW SUPPLIED

Tolterodine tartrate tablets 1 mg (white, round, biconvex, film-coated tablets engraved with arcs above and below the letters "TO") and tolterodine tartrate tablets 2...

Did you find an answer to your question? Yes No

PATIENT INFORMATION
tolterodine tartrate tablets

Read the Patient Information that comes with tolterodine tartrate tablets before you start using it and each time you get a refill. There may be new...

Did you find an answer to your question? Yes No

This product's label may have been updated. For current full prescribing information, please visit www.greenstonellc.com.

...

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event